Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
DR. REDDY'S LABORATORIES INC. v. AMARIN PHARMA, INC. et al
Case Number:
2:21-cv-10309
Court:
Nature of Suit:
Companies
Sectors & Industries:
-
March 02, 2023
Antitrust Suit Against Amarin Pharma Forges Ahead
A New Jersey judge largely refused to toss a lawsuit accusing Amarin Pharma of hoarding the active pharmaceutical ingredients needed to produce generic versions of its cardiovascular drug Vascepa, finding that it was possible Amarin acted in bad faith.
-
April 28, 2021
Dr. Reddy's Says Amarin Delaying Heart Drug Competition
Dr. Reddy's Laboratories Inc. has said that Amarin Pharma is trying to hinder generic competition of its heart drug Vascepa by cutting deals that keep generic makers from getting their hands on a key ingredient.